| 形态 | Liquid |
|---|---|
| 宿主种属 | Rabbit |
| 克隆性 | Polyclonal |
| 抗体亚型 | IgG |
| 纯化方式 | Purified by antigen affinity column. |
| 内毒素水平 | Please contact with the lab for this information. |
| 应用 | ELISA, IHC, WB |
| 种属反应性 | Human |
| 靶标 | CYP4F22, Cytochrome P450 4F22, EC:1.14.14.177, Ultra-long-chain fatty acid omega-hydroxylase |
| 免疫原 | E. coli - derived recombinant Human CYP4F22 (Asn66-Ala531). |
| 储存缓冲液 | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
| 产品使用说明 | ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000 |
| 登录号 | Q6NT55 |
| 背景信息 | Ultra-long-chain fatty acid omega-hydroxylase (CYP4F22) is a ~61 kDa protein. A cytochrome P450 monooxygenase involved in epidermal ceramide biosynthesis. Hydroxylates the terminal carbon (omega-hydroxylation) of ultra-long-chain fatty acyls (C28-C36) prior to ceramide synthesis. Contributes to the synthesis of three classes of omega-hydroxy-ultra-long chain fatty acylceramides having sphingosine, 6-hydroxysphingosine and phytosphingosine bases, all major lipid components that underlie the permeability barrier of the stratum corneum. Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase). 1. Ohno, Y. et al. (2015) Proceedings of the National Academy of Sciences of the United States of America 112, 7707-12. PMID: 26056268 |
| 备注 | For research use only |
| 产品名称 | 点击数 |
|---|---|
| 倍硫磷单抗 | 6303 |
| 多菌灵/阿苯达唑二合一单抗 | 6377 |
| 三氯噻嗪单抗 | 6469 |
| 吡唑醚菌酯单抗 | 6688 |
| 烯酰吗啉单抗 | 6507 |
| 抑霉唑单抗 | 6233 |
| 恶醚唑(苯醚甲环唑)单抗 | 6407 |
| 赛拉嗪(甲苯噻嗪)单抗 | 6424 |
| 辛硫磷单抗 | 6498 |
| 多效唑单抗 | 6368 |
| 对硫磷单抗 | 6566 |
| 丙溴磷单抗 | 6613 |
| 戊唑醇单抗 | 6606 |
| 莠去津单抗 | 6482 |
| 灭蝇胺单抗 | 6176 |
| 尼卡巴嗪代谢物(DNC)单抗 | 6464 |
| 2.4-二氯苯氧乙酸单抗 | 6308 |
| 甲基对硫磷单抗 | 6389 |
| 左旋咪唑单抗 | 6319 |
| 三唑磷单抗 | 6397 |